Masashi Kishiwada

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Shuji Isaji, Shugo Mizuno, John A. Windsor et al. · Pancreatology · 2017 · 751 citations · Full text

Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy

Rie Sato, Masashi Kishiwada, Naohisa Kuriyama et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2014 · 51 citations

Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3—T4 pancreatic cancer patients treated with preoperative gemcitabine‐based chemoradiotherapy

Yasuhiro Murata, Takashi Hamada, Masashi Kishiwada et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2011 · 50 citations

Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer

Aoi Hayasaki, Shuji Isaji, Masashi Kishiwada et al. · Cancers · 2018 · 50 citations · Full text

Influence of preoperative anti‐cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the <scp>J</scp>apanese <scp>S</scp>ociety of <scp>H</scp>epato‐<scp>B</scp>iliary‐<scp>P</scp>ancreatic <scp>S</scp>urgery

Fuyuhiko Motoi, Michiaki Unno, Hidenori Takahashi et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2013 · 48 citations